Cyclic dinucleotides as sting agonists
US11021511B2 · kind B2 · utility
0Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2018 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Jan 26, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7084
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compounds, compositions and methods for treating of diseases, syndromes, or disorders that are affected by the modulation of STING. Such compounds are represented by Formula (I) as follows: wherein R1H, R1K, R1J, and R2L are defined herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.